INTRODUCTIONJanus kinase (JAK) inhibitors are increasingly prescribed for inflammatory and autoimmune diseases, including atopic dermatitis (AD), alopecia areata (AA), psoriasis/psoriatic arthritis (PsO/PsA), and inflammatory bowel disease (IBD).1-2 Their use has…
Read More
INTRODUCTIONEczema is a prevalent, chronic skin condition with the highest burden among skin disorders globally, affecting approximately 20% of children and up to 10% of adults.1,2 The condition is characterized…
Read More
INTRODUCTIONPatients are increasingly turning to social media for disease/treatment advice and support.1 This has varying benefits2 but involves the risk of inaccurate information.3,4 Reddit, a news/social content discussion platform site…
Read More
INTRODUCTIONTirzepatide is a dual glucagon-like pedtide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) agonist and is primarily used to improve glycemic control along with weight reduction. It has also demonstrated anti-inflammatory…
Read More
INTRODUCTIONAtopic dermatitis (AD) is a chronic inflammatory skin condition characterized by intense pruritus and recurrent flares.1 Despite advances in biologic therapies targeting key cytokines involved in AD, treatment challenges remain…
Read More
INTRODUCTIONMedicare Part B spending on skin substitute products rose from $256 million in 2019 to more than $10 billion in 2024.1 A 2025 brief report first documented this trajectory in…
Read More
INTRODUCTIONPsoriasis is a chronic inflammatory skin disorder known to be linked to type 2 diabetes mellitus (T2DM), with 11.6% of psoriasis patients having comorbid T2DM.1 Glucagon-like peptide-1 receptor agonists (GLP-1…
Read More
Dear Editor, Psoriasis is recognized as a systemic disease with various comorbidities that increase disease burden and complicate treatment.1 Research has highlighted its systemic impacts, as well as worsened mental…
Read More
To the Editor, Eight percent (8%) of adults are affected by contact allergies.1 Patch testing is the gold standard for diagnosis of allergic contact dermatitis (ACD). Results are difficult to…
Read More
To the Editor, While biologic medications are frequently used to treat inflammatory skin diseases, patients have experienced paradoxical skin diseases arising from treatment.1 The onset of new hidradenitis suppurativa (HS)…
Read More
INTRODUCTIONPsoriasis is a chronic, immune-mediated inflammatory condition that affects approximately 3% of the adult population in the United States (US) and is characterized by the rapid proliferation of keratinocytes, resulting…
Read More
To the Editor, Psoriasis (PsO) is a chronic inflammatory disease associated with significant psychiatric comorbidity.1 Emerging evidence suggests that inflammatory pathways in PsO may contribute to neuroinflammation and mood symptoms,…
Read More
